z-logo
open-access-imgOpen Access
Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issue
Author(s) -
Vincenzo Di Nunno,
Giorgio Frega,
Lidia Gatto,
Giovanni Brandi,
Francesco Massari
Publication year - 2019
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2018-0758
Subject(s) - lenvatinib , medicine , sorafenib , cabozantinib , pazopanib , sunitinib , oncology , everolimus , hepatocellular carcinoma , regorafenib , cancer , colorectal cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom